Western Media Focusses On Big Pharma’s Search for a Coronavirus Vaccine While Suppressing Coverage of High Dose Intravenus Vitamin C to Save Lives in China – Centre for Research on Globalization
Dr. Andrew W. Saul, Editor in chief of the Orthomolecular Medicine News Service, sums up the Western big pharma approach nicely when he says:
“Medical orthodoxy obsessively focuses on searching for a vaccine and/or drug for coronavirus COVID-19). While they are looking for what would be fabulously profitable approaches, we have with vitamin C an existing, plausible, clinically demonstrated method to treat what coronavirus patients die from: severe acute respiratory syndrome, or pneumonia.’’
Over the last decade Dr Mao has been using high-dose intravenous vitamin C (IVC) to treat patients with a variety of acute medical conditions ranging from pancreatitis and sepsis to surgical wound healing. When the coronavirus epidemic first broke out he and several other colleagues thought that high-dose intravenous C could be a potential treatment for patients presenting with the coronavirus. Their recommendation for the use of high-dose intravenous vitamin C as a treatment was adopted by the Shanghai expert team.
Dr. Richard Cheng, an American-Chinese doctor currently based in Shanghai has given a report of this meeting. He notes that:
“Dr. Mao stated that his group treated ~50 cases of moderate to severe cases of Covid-19 infection with high dose IVC. The IVC dosing was in the range of 10,000 mg – 20,000 mg a day for 7-10 days, with 10,000 mg for moderate cases and 20,000 for more severe cases, determined by pulmonary status (mostly the oxygenation index) and coagulation status. All patients who received IVC improved and there was no mortality. Compared to the average of a 30-day hospital stay for all Covid-19 patients, those patients who received high dose IVC had a hospital stay about 3-5 days shorter than the overall patients. Dr. Mao discussed one severe case in particular who was deteriorating rapidly. He gave a bolus of 50,000 mg IVC over a period of 4 hours. The patient’s pulmonary (oxygenation index) status stabilized and improved as the critical care team watched in real time. There were no side effects reported from any of the cases treated with high dose IVC. ‘’
Dr. Andrew G. Weber, a pulmonologist and critical-care specialist affiliated with two Northwell Health facilities on Long Island, has said that coronavirus patients admitted to intensive care immediately receive 1,500 mg of intravenous vitamin C. This dosage is then repeated 3-4 times a day.
According to Dr. Weber this treatment regime is based upon the experimental use of high-dose vitamin C in Shanghai’s hospitals. He told the New York Post:
“The patients who received vitamin C did significantly better than those who did not get vitamin C. It helps a tremendous amount, but it is not highlighted because it’s not a sexy drug.”
via Western Media Focusses On Big Pharma’s Search for a Coronavirus Vaccine While Suppressing Coverage of High Dose Intravenus Vitamin C to Save Lives in China – Global ResearchGlobal Research – Centre for Research on Globalization